Nuvation Bio
NUVB
73 hedge funds and large institutions have $1.48B invested in Nuvation Bio in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 12 closing their positions.
973% more capital invested
Capital invested by funds: $138M → $1.48B (+$1.34B)
333% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 12
121% more funds holding
Funds holding: 33 → 73 (+40)
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
12.04% less ownership
Funds ownership: 79.23% → 67.19% (-12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$361M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$315M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$148M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$96.4M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$84.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$14.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.85M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$4.19M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$3.52M |
| 5 |
AGM
Alpine Global Management
New York
|
-$2.34M |
NUVB Hedge Fund Activity: Q1 2021 in Review
73 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q1 2021, worth a combined $1.48B — up 973% from $138M a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new NUVB positions and 12 closed out — a net gain of 40 holders — while 12 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $361M. The largest seller was Castle Creek Arbitrage, exiting entirely with an estimated $14.4M sold.
- 73 institutional investors held Nuvation Bio (NUVB) as of Q1 2021, up from 33 in Q4 2020.
- Funds reported $1.48B of Nuvation Bio stock for Q1 2021, up 973% quarter-over-quarter.
- 52 funds opened new Nuvation Bio positions in Q1 2021 and 12 closed out, a net change of +40 holders.
- The largest Nuvation Bio buyer in Q1 2021 was Fidelity Investments, an estimated $361M added.
- The largest Nuvation Bio seller in Q1 2021 was Castle Creek Arbitrage, an estimated $14.4M sold.
Based on aggregated 13F filings for Q1 2021.